Main Article Content

Abstract

The current research investigated the COVID-19 is spread vigorously in China, USA, France, Italy, Germany, and European countries and Iran Pakistan being as a neighbor country of china & IranOne was for the incoming Pakistani from various countries, such as Iran, China, Afghanistan, and India. The other was arranged inside various hospitals for COVID-19 positive cases. As hundreds and thousands of Pakistani were in Iran for religious purposes, they were. Most of the students and businessmen, inside China, were not allowed to come back. Handling of large scale influx from Iran was the main problem. Out of the total COVID-19 cases, 78 percent of cases were reported from visitors coming from Iran. Pakistan announced the closure of all schools, colleges & universities with a partial lockdown across the country for major cities.

Keywords

COVID-19 Pakistan religious purposes

Article Details

How to Cite
[1]
Dr. Faiz Muhammad Shaikh, Ali Raza Memon and Kashaf Shaikh 2020. Impact of COVID-19 caronavirus on poverty in Pakistan: a case study of Sindh . International Journal on Integrated Education. 3, 6 (Jun. 2020), 72-83. DOI:https://doi.org/10.31149/ijie.v3i6.415.

References

  1. European Centre for Disease Prevention and Control data. Geographical distribution of 2019- nCov cases. Available online: (https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases) (accessed on 05 February 2020)
  2. World Health Organization, 2019- nCoV Situation Report-22 on 12 February 2020. https://www.who.int/docs/default- source/coronavirus/situation-reports/
  3. Gralinski L, Menachery V. Return of the Coronavirus: 2019- nCoV, Viruses 2020;12:135. [CrossRef ]
  4. Chen Z, Zhang W, Lu Y, et al. From SARS-CoV to Wuhan 2019- nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends: Cell Press 2020. [CrossRef ]
  5. Luk HK, Li X, Fung J, Lau SK, Woo PC. Molecular epidemiology, evolution, and phylogeny of SARS coronavirus. Infection, Genetics and Evolution 2019;71:21–30. [CrossRef ]
  6. Coronavirinae in ViralZone. Available online: https://viralzone. expasy.org/785 (accessed on 05 February 2019).
  7. Subissi L, Posthuma CC, Collet A, Zevenhoven-Dobbe JC, Gorbalenya AE, Decroly E, et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc Natl Acad Sci USA 2014;111:E3900–E3909. [CrossRef ]
  8. Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyl- peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003;40:209–94. [CrossRef ]
  9. Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, et al. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates the innate immune response. Virology 2014;454–455:197–205. [CrossRef ]
  10. Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis. J Infect Dis 2014;209:1331–42. [CrossRef ]
  11. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proceedings of the Society for Experimental Biology and Medicine 1966;121:190–3. [CrossRef ]
  12. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;264–6. [CrossRef ]
  13. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States The New England Journal of Medicine 2020. [CrossRef ]
  14. WHO. Emergencies preparedness, response. Pneumonia of unknown origin – China. Disease outbreak news. Available online: https:// HYPERLINK "http://www.who.int/csr/don/12- January-2020-novel-coronavirus-china/en/" www.who.int/ csr/don/12-January-2020-novel-coronavirus-china/en/ (accessed on 05 February 2020)
  15. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany, 30.01.2020. [CrossRef ]
  16. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020, published online Jan 29, https://doi.org/10.1016/ S0140-6736(20)30211-7.
  17. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; published online Jan 24. HYPERLINK "https://doi. org/10.1016/S01406736(20)301835" https://doi.org/10.1016/
  18. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N England J Medicine, Publish online Jan 29. DOI: 10.1056/NEJMoa2001017 [CrossRef ]
  19. Wang C, Horby PW, Harden FG, Gao GF. A novel coronavirüs outbreak of global health concern. Lancet 2020, publish on- lined Jan 24, https://doi.org/10.1016/S0140-6736(20)30185-9.
  20. Arabi YM, Alothman A, Balkhy, et al. Treatment of the Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2016;19;81. [CrossRef ]
  21. Warren TK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature2016;531:381–5. [CrossRef ]
  22. Jordan PC, et al. Initiation, extension, and termination ofRNA synthesis by a paramyxovirus polymerase. PLoSPathog 2018;14:e1006889. [CrossRef ]
  23. Cockrell AS, et al. A mouse model for MERS coronavirus- induced acute respiratory distress syndrome. Nat. Microbiol 2016;2:16226. [CrossRef ]
  24. Brown AJ, et al. Broad-spectrum antiviral remdesivir inhibit- its human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antivir Res 2019;169:104541. [CrossRef ]
  25. 2019 Novel Coronavirus.Prevention and Treatment. Available online: https://www.cdc.gov/coronavirus/2019-ncov/about/ prevention-treatment.html (accessed on 05 February 2020)
  26. What to do if you are sick with 2019 Novel Coronavirus. Available online:https://www.cdc.gov/coronavirus/2019-ncov/ about/steps-when-sick.html (accessed on 05 February 2020)
  27. Shen M.; Peng Z.; Xiao.; Zhang L. Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China.